These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis]. Huang YL; Li SY; Zhao XY; Fan LP; Lin WC; Zhou ZH; Cheng J; Liu L Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):510-4. PubMed ID: 22809603 [TBL] [Abstract][Full Text] [Related]
6. Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis? Vieira T; Schwartz I; Muñoz V; Pinto L; Steiner C; Ribeiro M; Boy R; Ferraz V; de Paula A; Kim C; Acosta A; Giugliani R Am J Med Genet A; 2008 Jul; 146A(13):1741-7. PubMed ID: 18546277 [TBL] [Abstract][Full Text] [Related]
7. Incidence of the mucopolysaccharidoses in Northern Ireland. Nelson J Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322 [TBL] [Abstract][Full Text] [Related]
9. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII. Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054 [TBL] [Abstract][Full Text] [Related]
10. Prevalence rates of mucopolysaccharidoses in Poland. Jurecka A; Ługowska A; Golda A; Czartoryska B; Tylki-Szymańska A J Appl Genet; 2015 May; 56(2):205-10. PubMed ID: 25472774 [TBL] [Abstract][Full Text] [Related]
11. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Lin HY; Lin SP; Chuang CK; Niu DM; Chen MR; Tsai FJ; Chao MC; Chiu PC; Lin SJ; Tsai LP; Hwu WL; Lin JL Am J Med Genet A; 2009 May; 149A(5):960-4. PubMed ID: 19396827 [TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903 [TBL] [Abstract][Full Text] [Related]
13. [Enzymatic diagnosis of 47 cases with mucopolysaccharidosis]. Zhang HW; Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Gu XF Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):276-80. PubMed ID: 19555566 [TBL] [Abstract][Full Text] [Related]
14. [Mucopolysaccharidosis: 20-year enzymatic diagnosis in Cuba]. Menéndez-Sainz C; Gonzaléz-García S; Peña-Sánchez M; Zaldívar-Muñoz C; González-Quevedo A Rev Neurol; 2009 Nov 1-15; 49(9):458-62. PubMed ID: 19859885 [TBL] [Abstract][Full Text] [Related]
15. Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt. Fateen E; Abdallah ZY; Nazim WS; Ibrahim M; Radwan A Heliyon; 2021 Aug; 7(8):e07830. PubMed ID: 34471711 [TBL] [Abstract][Full Text] [Related]
16. Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions. Josahkian JA; Trapp FB; Burin MG; Michelin-Tirelli K; Magalhães APPS; Sebastião FM; Bender F; Mari JF; Brusius-Facchin AC; Leistner-Segal S; Málaga DR; Giugliani R Genet Mol Biol; 2021; 44(1):e20200138. PubMed ID: 33503199 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of mucopolysaccharidoses (MPS) in United States: challenges and opportunities. Puckett Y; Mallorga-Hernández A; Montaño AM Orphanet J Rare Dis; 2021 May; 16(1):241. PubMed ID: 34051828 [TBL] [Abstract][Full Text] [Related]
18. Mucopolysaccharidosis enzyme production by bone marrow and dental pulp derived human mesenchymal stem cells. Jackson M; Derrick Roberts A; Martin E; Rout-Pitt N; Gronthos S; Byers S Mol Genet Metab; 2015 Apr; 114(4):584-93. PubMed ID: 25748347 [TBL] [Abstract][Full Text] [Related]
19. Incidence of mucopolysaccharidoses in Tunisia. Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Chemli J; Monastiri K; Chaabouni M; Sanhagi H; Zouari B; Kaabachi N; Ben Dridi MF Tunis Med; 2009 Nov; 87(11):782-5. PubMed ID: 20209839 [TBL] [Abstract][Full Text] [Related]
20. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy. Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]